Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,160,953
-
Total 13F shares
-
14,858,398
-
Share change
-
+7,020
-
Total reported value
-
$121,245,735
-
Put/Call ratio
-
212%
-
Price per share
-
$8.16
-
Number of holders
-
106
-
Value change
-
-$9,234
-
Number of buys
-
41
-
Number of sells
-
51
Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q3 2020
As of 30 Sep 2020,
AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by
106 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,858,398 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Handelsbanken Fonder AB, Herald Investment Management Ltd, Senvest Management, LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, and Taylor Frigon Capital Management LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.